AIM
EGRX

Assured Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Assured Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,826
Closed -$648K – 917
2019
Q1 		$648K Buy
12,826
+12,438
+3,206% +$553K 0.01% 498
2018
Q4 		$16K Sell
388
-1,231
-76% -$63.4K ﹤0.01% 1075
2018
Q3 		$112K Sell
1,619
-1,680
-51% -$127K ﹤0.01% 1025
2018
Q2 		$250K Sell
3,299
-3,484
-51% -$219K ﹤0.01% 964
2018
Q1 		$357K Buy
+6,783
New +$394K 0.01% 868

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assured Investment Management's EGRX Position: Q2 2019 in Review

Assured Investment Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2019, closing a stake of 12,826 shares — an estimated $648K sold.

Assured Investment Management first reported a position in EGRX in Q1 2018 and held it in 5 quarters. The position peaked at $648K in Q1 2019. 180 funds tracked by Wall St. Rank hold EGRX as of Q2 2019.

  • Assured Investment Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 12,826 Eagle Pharmaceuticals, Inc. shares in Q2 2019, an estimated $648K.
  • Assured Investment Management first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Eagle Pharmaceuticals, Inc. position peaked at $648K in Q1 2019.
  • 180 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.